Suppr超能文献

宫颈癌患者前哨淋巴结的拓扑分布

Topographic distribution of sentinel lymph nodes in patients with cervical cancer.

作者信息

Marnitz Simone, Köhler Christhardt, Bongardt Stefanie, Braig Ute, Hertel Hermann, Schneider Achim

机构信息

Department of Radiooncology, Charite Universitätsmedizin Berlin, Germany.

出版信息

Gynecol Oncol. 2006 Oct;103(1):35-44. doi: 10.1016/j.ygyno.2006.01.061. Epub 2006 Apr 5.

Abstract

BACKGROUND

Since the introduction of the sentinel concept in cervical cancer in 1999, various studies have been demonstrated the feasibility, detection rate and sensitivity and rate of false-negative sentinel lymph nodes (SLN). There are only limited data regarding the mapping of the removed SLN. A correlation between the localization of SLN and the tumor stage, histology or marker substance has never been investigated.

METHODS

Between 2/2000 and 6/2005, the SLN distribution of 151 patients with histologically confirmed cervical cancer (FIGO stages IA n = 21, IB n = 95, IIA n = 14, IIB n = 18, IIIB n = 2, IVA n = 1), who participated in the ongoing "Uterus 3" sentinel study of the German Association of Gynecologic Oncologists (AGO), was retrospectively analyzed with respect to the histology, tumor stage and detection substance. The tumors comprised mostly of squamous cell carcinomas (75.5%) with a smaller fraction of adenocarcinomas (24.5%).

RESULTS

Altogether, 406 SLN, an average of 2.7 (1-7) SLN per patient, were removed. More than one SLN was detected in 111 patients (73.5%). SLN were found unilaterally in 70 patients (46.4%) und bilaterally in 81 patients (53.6%). SLN sites were paraaortic in 4%, common iliac in 5%, external iliac in 5%, internal iliac in 8%, interiliac in 71% and parametric in 7%. Irrespective of the detection drug applied, most SLN were interiliac (blue 70%, TC 67%, TC and blue 71%). Combined application of technetium and blue dye revealed significantly more SLN in the paraaotic region (P = 0.006). Adenocarcinomas and squamous carcinomas did not differ in the distribution of SLN (P = 0.205). The majority of SLN are interiliac in all tumor stages (FIGO IA 76%, IB 68%, IIA 61%, IIB 83%, III and IV 88%).

CONCLUSIONS

Removal of SLN in the external iliac, interiliac and obturator area enables evaluation of more than 80% of all SLN. The pattern of SLN is independent from histology and tumor stage. Combined use of technetium and blue dye detects sentinels more frequently in the paraaortic region than a single marker.

摘要

背景

自1999年引入宫颈癌前哨淋巴结概念以来,多项研究已证实前哨淋巴结(SLN)的可行性、检出率、敏感性及假阴性率。关于切除的SLN定位的数据有限。从未研究过SLN的定位与肿瘤分期、组织学或标记物质之间的相关性。

方法

在2000年2月至2005年6月期间,对151例经组织学确诊的宫颈癌患者(国际妇产科联盟(FIGO)分期:IA期21例,IB期95例,IIA期14例,IIB期18例,IIIB期2例,IVA期1例)的SLN分布进行回顾性分析,这些患者参与了德国妇科肿瘤学家协会(AGO)正在进行的“子宫3”前哨淋巴结研究,分析内容包括组织学、肿瘤分期和检测物质。肿瘤大多为鳞状细胞癌(75.5%),腺癌比例较小(24.5%)。

结果

共切除406枚SLN,平均每位患者2.7枚(1 - 7枚)。111例患者(73.5%)检测到不止一枚SLN。70例患者(46.4%)SLN为单侧发现,81例患者(53.6%)为双侧发现。SLN位于腹主动脉旁的占4%,髂总动脉的占5%,髂外动脉的占5%,髂内动脉的占8%,髂间的占71%,宫旁的占7%。无论应用何种检测药物,大多数SLN位于髂间(蓝色示踪剂标记的占70%,放射性核素标记的占67%,放射性核素和蓝色示踪剂标记的占71%)。放射性核素与蓝色染料联合应用在腹主动脉旁区域发现的SLN明显更多(P = 0.006)。腺癌和鳞状细胞癌在SLN分布上无差异(P = 0.205)。在所有肿瘤分期中,大多数SLN位于髂间(FIGO IA期76%,IB期68%,IIA期61%,IIB期83%,III期和IV期88%)。

结论

切除髂外、髂间和闭孔区域的SLN能够评估所有SLN的80%以上。SLN的分布模式与组织学和肿瘤分期无关。放射性核素与蓝色染料联合使用比单一标记物更频繁地在腹主动脉旁区域检测到前哨淋巴结。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验